
Disc Medicine, Inc.
Nasdaq · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
Disc Medicine is a clinical-stage biopharmaceutical company developing therapies for hematologic diseases, including anemias and blood disorders related to iron and heme metabolism.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Yu Jonathan Yen-WenChief Operating Officer | Sell | $731K | 8,796at $83.12 | Aug 25, 2026 |
| Yu Jonathan Yen-WenChief Operating Officer | Sell | $25K | 300at $82.53 | Aug 24, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable IRON activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.